Stay updated on Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Sign up to get notified when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.

Latest updates to the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page
- Check2 days agoChange DetectedMinor UI-footer update: Revision: v3.4.2 was added and Revision: v3.4.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision: v3.4.1 has been added and the previous Revision: v3.4.0 has been removed.SummaryDifference0.0%

- Check16 days agoChange DetectedAdded a glossary toggle to the page and updated metadata to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The prior lowercase labels were removed or reformatted, including 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'.SummaryDifference0.1%

- Check30 days agoChange DetectedRevision updated to v3.3.4 from v3.3.3; no substantive content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check51 days agoChange DetectedIntroduced a centralized Locations section with state-by-state site listings and bumped the revision to v3.3.3, replacing the previous per-state location subsections.SummaryDifference1%

- Check66 days agoChange DetectedMajor study details such as objectives, endpoints, eligibility criteria, and enrollment appear unchanged; only formatting tweaks and a timestamp update are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Talimogene Laherparepvec and Nivolumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talimogene Laherparepvec and Nivolumab Combination Clinical Trial page.